Mohamed El Kassas
My co-authors include
sherief Abd-Elsalam
Shereen Abdel Alem
Dr Mohamed Alboraie
My Publications
<p>Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular C...
Journal of Hepatocellular Carcinoma
November 2019
Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based t...
Expert Review of Gastroenterology & Hepatology
August 2019
High SVR rate following retreatment of non-sustained virological responders to sofosbuv...
Expert Review of Gastroenterology & Hepatology
June 2019
Diabetes association with liver diseases: an overview for clinicians
Endocrine Metabolic & Immune Disorders - Drug Targets
November 2018
Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in E...
Alimentary Pharmacology & Therapeutics (Suppl)
June 2018
Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis ...
Liver International
May 2018
A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: Ravidasvir
Current Drug Discovery Technologies
April 2018
Professor of Internal Medicine, Consultant Hepatologist
Alimentary Pharmacology & Therapeutics (Suppl)
November 2017
After successful hepatitis C virus antiviral therapy: It looks that normal alanine amin...
Journal of Clinical Laboratory Analysis
July 2017
HCV in EGYPT
Hepatic Medicine Evidence and Research
July 2017
Discovery and preclinical development of dasabuvir for the treatment of hepatitis C inf...
Expert Opinion on Drug Discovery
May 2017
Hepatitis C infection in Egypt: prevalence, impact and management strategies
Hepatic Medicine Evidence and Research
May 2017
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
Journal of Viral Hepatitis
February 2017
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy i...
Liver International
November 2016